As Singapore treats COVID-19 as an endemic disease, financing support for COVID-19 testing and treatment will be scaled back and re-aligned to that of other acute illnesses. From 1 April 2023^, the following changes will be implemented:
Hospitals and COVID-19 Treatment Facilities (CTFs) |
|
Community Isolation Facilities (CIFs) |
|
Primary care settings (Polyclinics and GP clinics) |
|
^ Applies to new admissions in public hospitals, COVID-19 Treatment Facilities and Community Isolation Facilities from 1 April 2023
* Includes Singapore Citizens, Permanent Residents and Long-Term Pass Holders (SCs/PRs/LTPHs
COVID-19 vaccinations and oral antivirals will remain fully subsidised for clinically eligible patients in outpatient (including primary care), ambulatory settings of public hospitals and nursing homes, until further notice. Free telemedicine support will also be available to patients with a higher risk of severe COVID-19, such as the immunocompromised and individuals with some comorbidities.
For more information, please refer to MOH’s press release.
